Using hydrogels to treat hair loss in alopecia areata
Hydrogel Therapies for Alopecia Areata
['FUNDING_CAREER'] · UNIVERSITY OF PENNSYLVANIA · NIH-11136601
This study is exploring a new gel treatment for people with alopecia areata, a condition that causes hair loss, to see if it can help stimulate hair regrowth in a safe and effective way.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11136601 on ClinicalTrials.gov |
What this research studies
This research investigates the use of hydrogel therapies to treat alopecia areata, an autoimmune condition that causes hair loss. The approach focuses on developing biocompatible materials that can be applied topically to the affected areas, aiming to stimulate hair regrowth. The research team, led by Dr. Leo Wang at the University of Pennsylvania, includes experts in dermatology and biomaterials, ensuring a comprehensive methodology that combines clinical insights with advanced material science. The project will also involve animal models to assess the effectiveness of these therapies before moving to human trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alopecia areata who are seeking new treatment options.
Not a fit: Patients with other forms of hair loss not related to autoimmune conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for individuals suffering from alopecia areata.
How similar studies have performed: Previous research has shown promise in using biomaterials for treating skin and hair disorders, indicating potential for success in this novel approach.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, LEO LE — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: WANG, LEO LE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.